JP2004529901A5 - - Google Patents

Download PDF

Info

Publication number
JP2004529901A5
JP2004529901A5 JP2002569842A JP2002569842A JP2004529901A5 JP 2004529901 A5 JP2004529901 A5 JP 2004529901A5 JP 2002569842 A JP2002569842 A JP 2002569842A JP 2002569842 A JP2002569842 A JP 2002569842A JP 2004529901 A5 JP2004529901 A5 JP 2004529901A5
Authority
JP
Japan
Prior art keywords
diazabicyclo
heptane
group
quinolinyl
syndrome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002569842A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004529901A (ja
JP4294958B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/DK2002/000133 external-priority patent/WO2002070522A1/en
Publication of JP2004529901A publication Critical patent/JP2004529901A/ja
Publication of JP2004529901A5 publication Critical patent/JP2004529901A5/ja
Application granted granted Critical
Publication of JP4294958B2 publication Critical patent/JP4294958B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002569842A 2001-03-02 2002-02-28 新規2,5−ジアザビシクロ[2.2.1]ヘプタン誘導体 Expired - Fee Related JP4294958B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200100344 2001-03-02
PCT/DK2002/000133 WO2002070522A1 (en) 2001-03-02 2002-02-28 Novel 2,5-diazabicyclo[2.2.1]heptane derivatives

Publications (3)

Publication Number Publication Date
JP2004529901A JP2004529901A (ja) 2004-09-30
JP2004529901A5 true JP2004529901A5 (enExample) 2009-02-05
JP4294958B2 JP4294958B2 (ja) 2009-07-15

Family

ID=8160337

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002569842A Expired - Fee Related JP4294958B2 (ja) 2001-03-02 2002-02-28 新規2,5−ジアザビシクロ[2.2.1]ヘプタン誘導体

Country Status (12)

Country Link
US (1) US7329754B2 (enExample)
EP (1) EP1368348B1 (enExample)
JP (1) JP4294958B2 (enExample)
CN (1) CN1331864C (enExample)
AT (1) ATE287404T1 (enExample)
AU (1) AU2002233181B2 (enExample)
CA (1) CA2438815A1 (enExample)
DE (1) DE60202667T2 (enExample)
DK (1) DK1368348T3 (enExample)
MX (1) MXPA03007895A (enExample)
NZ (1) NZ527006A (enExample)
WO (1) WO2002070522A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7084156B2 (en) 2001-11-27 2006-08-01 Merck & Co., Inc. 2-Aminoquinoline compounds
BRPI0908807A2 (pt) * 2008-02-15 2015-07-28 Hoffmann La Roche Derivados de 3-alquil-piperazina e usos dos mesmos

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN166416B (enExample) * 1985-09-18 1990-05-05 Pfizer
US5196548A (en) * 1989-05-11 1993-03-23 Pfizer Inc. Preparation of diazabicyclic Intermediates
JPH06228138A (ja) * 1993-02-03 1994-08-16 Fujisawa Pharmaceut Co Ltd ピリドシンノリン化合物またはその塩及びこれを含有する抗菌剤
US5478939A (en) * 1994-07-20 1995-12-26 American Cyanamid Company (R,R) and (S,S) 2,5-diazabicyclo [2,2,1]heptane derivatives
US5561127A (en) * 1994-12-19 1996-10-01 Allelix Biopharmaceuticals, Inc. Muscarinic receptor ligands
FR2786769B1 (fr) 1998-12-04 2002-10-25 Synthelabo Derives de 2,5-diazabicyclo[2.2.1]heptane, leur preparation et leur application en therapeutique
DE60006213T2 (de) * 1999-01-29 2004-07-29 Abbott Laboratories, Abbott Park Diazabicyloderivate als nikotin-acetylcholin-rezeptorliganden
US6852721B2 (en) * 2000-05-25 2005-02-08 Targacept, Inc. Pharmaceutical compositions and methods for use
US6552015B2 (en) * 2000-08-03 2003-04-22 Pfizer Inc. Azabicycloalkane derivatives and therapeutic uses thereof

Similar Documents

Publication Publication Date Title
JP2005524713A5 (enExample)
CN1181074C (zh) 制备三亚乙基二胺(teda)的方法
JP2009538867A5 (enExample)
JP2005538187A5 (enExample)
JP2006508109A5 (enExample)
JP2010520265A5 (enExample)
JP2004527467A5 (enExample)
JP2009538870A5 (enExample)
JP2009538869A5 (enExample)
RU2005101748A (ru) Новые хинуклидиновые производные и их применение
RU2008139481A (ru) Новые 1,4-диаза-бицикло[3.2.2]нонил-оксадиазолильные производные и их медицинское применение
JP2006503062A5 (enExample)
JP2005530814A5 (enExample)
JP2009537599A5 (enExample)
JP2006519868A5 (enExample)
JP2009526776A5 (enExample)
JP2004529901A5 (enExample)
JP2019501923A (ja) 極性非プロトン性溶媒を用いたn−[4−(1−アミノエチル)−フェニル]−スルホンアミド誘導体のキラル分割方法
WO2006070349A3 (en) Novel process for preparing pramipexole and its optical isomeric mixture by reduction with sodium triacetoxyborohydride
JP2009537598A5 (enExample)
AU769005B2 (en) Method for the racemization of optically active amines
JP7411757B2 (ja) ベタイン基含有有機ケイ素化合物およびその成形物と製造方法
RU2019128576A (ru) Сокристаллы замещенных глициновых соединений и их применение
JP2005524712A5 (enExample)
WO2005000806A3 (en) Ligands for nicotinic acetylcholine receptors, and methods of making and using them